ドキサプラム塩酸塩水和物
ドキサプラム塩酸塩水和物 物理性質
- 融点 :
- 217-219°
- 貯蔵温度 :
- Sealed in dry,Room Temperature
- 溶解性:
- 水、アルコール、塩化メチレンに溶ける。
- InChIKey:
- ZOMBFZRWMLIDPX-UHFFFAOYSA-N
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
| RIDADR |
UN 2811 6.1 / PGIII |
|
|
| HSコード |
2934990002 |
|
|
| 毒性 |
LD50 orally in rats: 261 mg/kg (Goldenthal) |
|
|
| 絵表示（GHS） |
|
| 注意喚起語 |
危険 |
| 危険有害性情報 |
| コード |
危険有害性情報 |
危険有害性クラス |
区分 |
注意喚起語 |
シンボル |
P コード |
| H301 |
飲み込むと有毒 |
急性毒性、経口 |
3 |
危険 |
|
P264, P270, P301+P310, P321, P330,P405, P501 |
|
| 注意書き |
|
ドキサプラム塩酸塩水和物 価格
もっと(8)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01LKTD5992 |
ドキサプラム塩酸塩水和物
Doxapram Hydrochloride Hydrate |
7081-53-0 |
25mg |
￥22200 |
2024-03-01 |
購入 |
|
富士フイルム和光純薬株式会社(wako)
|
W01LKTD5992 |
ドキサプラム塩酸塩水和物
Doxapram Hydrochloride Hydrate |
7081-53-0 |
100mg |
￥69500 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
D2963000 |
European Pharmacopoeia (EP) Reference Standard
Doxapram hydrochloride European Pharmacopoeia (EP) Reference Standard |
7081-53-0 |
d2963000 |
￥19100 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
1225000 |
United States Pharmacopeia (USP) Reference Standard
Doxapram hydrochloride United States Pharmacopeia (USP) Reference Standard |
7081-53-0 |
200mg |
￥55400 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
BP135 |
British Pharmacopoeia (BP) Assay Standard
Doxapram hydrochloride British Pharmacopoeia (BP) Assay Standard |
7081-53-0 |
100MG |
￥33200 |
2023-06-01 |
購入 |
ドキサプラム塩酸塩水和物 化学特性,用途語,生産方法
効能
呼吸促進薬
商品名
ドプラム (キッセイ薬品工業)
説明
Doxapram is a central respiratory stimulant. It increases respiration and phrenic nerve activity in anesthetized cats at a dose of 1.0 mg/kg. Doxapram acts through carotid chemoreceptors, lacking activity in anesthetized cats following carotid denervation. Formulations containing doxapram have been used to increase respiration in patients with chronic pulmonary disease, respiratory depression induced by drug overdose, and to stimulate deep breathing post-anesthesia.
化学的特性
White or almost white, crystalline powder.
使用
antibacterial
定義
ChEBI: The monohydrate form of doxapram hydrochloride. A central and respiratory stimulant with a brief duration of action, it is used as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease,
nd of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
一般的な説明
Doxapram, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate (Dopram), has an obscuremolecular mechanism of action. Overall, it stimulatesrespiration by action on peripheral carotid chemoreceptors.It has use as a respiratory stimulant postanesthetically, afterCNS depressant drug overdose, in chronic obstructive pulmonarydiseases, and in the apneas. Dopram is administeredexclusively by intravenous injection. Because of the benzylalcohol content of the injectable formulation, Dopram mustnever be given to neonates.
ドキサプラム塩酸塩水和物 上流と下流の製品情報
原材料
準備製品
ドキサプラム塩酸塩水和物 生産企業
Global( 195)Suppliers
ドキサプラム塩酸塩水和物 スペクトルデータ(1HNMR)
7081-53-0(ドキサプラム塩酸塩水和物)キーワード:
- 7081-53-0
- 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinonehydrochloridehydr
- 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinonmonohydrochloride
- doxapramhydrochloridehydrate
- stimulexin
- 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-dephenyl-2-pyrrolidinone hydrochloride monohydrate
- DOXAPRAM HCL
- DOXAPRAM HYDROCHLORIDE
- doxapram hydrochloride monohydrate
- 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenyl-pyrrolidin-2-one hydrate hydrochloride
- 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one hydrate hydrochloride
- 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidone hydrate hydrochloride
- Doxapram Hydrochloride (200 mg)
- Doxapram Hydrochoride
- 2-Pyrrolidinone, 1-ethyl-4-2-(4-morpholinyl)ethyl-3,3-diphenyl-, monohydrochloride, monohydrate
- DOTHIEPINHYDROCHLORIDE,ANHYDROUS
- 2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, hydrochloride, hydrate (1:1:1)
- 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate
- Doxapram Hydrochloride Doxapram Hydrochloride
- 1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-Pyrrolidinone, monohydrochloride, monohydrate(8CI)
- 1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone, hydrochloride, hydrate(1:1:1)
- DoxapraM Hydrochloride, USP
- (4S)-1-ethyl-4-[2-(Morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one
- DoxapraM HCL API
- 1-Ethyl-4-(2-Morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloridehydrate
- 1-Ethyl-4-[2-(4-Morpholinyl)ethyl]-3,3-diphenyl-2-Pyrrolidinone, Monohydrochloride, Monohydrate (9CI)
- DoxapraM Hydrochoride Monohydrate
- Doxapram hydrochloride monohyd
- 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone hydrate hydrochloride
- Dopram hydrochloride hydrate
- DOPRAM HYDROCHLORIDE HYDRATE;STIMULEX HYDROCHLORIDE HYDRATE;RESPIRAM HYDROCHLORIDE HYDRATE
- ドキサプラム塩酸塩水和物
- ドキサプラム塩酸塩一水和物
- ドキサプラム塩酸塩水和物 (JP17)